Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EFLORNITHINE HYDROCHLORIDE
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
- Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
- Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
- DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Topical Eflornithine for Pseudofolliculitis Barbae: RCT
- Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
- Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
- Chemoprevention of Gastric Carcinogenesis
- Neuroblastoma Maintenance Therapy Trial
- Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
- Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
- Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
- Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
- S0820, Adenoma and Second Primary Prevention Trial
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
- Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
- Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
- Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
- Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
- Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis
- Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
- Evaluation of Eflornithine on Facial and Forearm Skin
- Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
- Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
- Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
- Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
- Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
- Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer
- Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
- Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
- Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
- Eflornithine in Treating Patients With Bladder Cancer
- Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Clinical trials list
click for details